UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the Securities

Exchange Act of 1934

 

Filed by the Registrant ☒

Filed by a Party other than the Registrant

Check the appropriate box:

 

  Preliminary Proxy Statement
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material Pursuant to §240.14a-12

 

MEDLEY CAPITAL CORPORATION

(Name of Registrant as Specified In Its Charter)

 

 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

 

  No fee required
     
  Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
     
    (1)  

Title of each class of securities to which transaction applies:

 

    (2)  

Aggregate number of securities to which transaction applies:

 

    (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

    (4)  

Proposed maximum aggregate value of transaction:

 

    (5)  

Total fee paid:

 

  Fee paid previously with preliminary materials
   
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
    (1)  

Amount Previously Paid:

 

    (2)  

Form, Schedule or Registration Statement No.:

 

    (3)  

Filing Party:

 

    (4)   Date Filed: 

 

 

 

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

Current Report Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 11, 2019

 

 

 

Medley Capital Corporation

(Exact Name of Registrant as Specified in its Charter)

 

 

 

    Delaware    
    (State or other jurisdiction of incorporation)    

 

1-35040   27-4576073
(Commission File Number)   (I.R.S. Employer Identification No.)

 

280 Park Avenue, 6th Floor East
New York, NY 10017

(Address of Principal Executive Offices and Zip Code)

 

Registrant’s telephone number, including area code: (212) 759-0777

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 2.02Results of Operations and Financial Condition.

 

On February 11, 2019, Medley Capital Corporation issued a press release announcing its financial results for the fiscal quarter ended December 31, 2018. The press release is included as Exhibit 99.1 to this Form 8-K.

 

Item 9.01Financial Statements and Exhibits.

 

(a) Not applicable.

 

(b) Not applicable.

 

(c) Not applicable.

 

(d) Exhibits.

 

Exhibit No.   Description
     
99.1   Press Release dated February 11, 2019

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 11, 2019 MEDLEY CAPITAL CORPORATION
     
  By: /s/ Richard T. Allorto, Jr.
  Name:  Richard T. Allorto, Jr.
  Title: Chief Financial Officer

 

2

 

 

Medley Capital Corporation Announces December 31, 2018 Financial Results and Merger Update

 

NEW YORK, NY (February 11, 2019) – Medley Capital Corporation (NYSE: MCC) (TASE: MCC) (the “Company”) today announced financial results for its fiscal first quarter ended December 31, 2018.

 

First Quarter Highlights

 

Net investment income of $0.03 per share
Adjusted net investment income of $0.05 per share excluding expenses associated with pending merger
Declared a dividend of $0.05 per share
Net asset value (“NAV”) of $5.61 per share
NAV decline of 1.1% from payment of dividend in excess of net investment income and 3.8% from market and credit related volatility

 

Merger Update

 

Adjourned shareholder vote to March 8th in light of the government shutdown
Expect to close the transaction in calendar Q1 2019
Post-merger dividend is expected to increase 166% from $0.05 per share this quarter to $0.133 per share on an equivalent basis1 for the first 12 months following the closing of the mergers; in addition the dividend will be paid monthly instead of quarterly
The transaction is expected to be accretive to net investment income2
The Combined Company3 will be internally managed, providing potential for a premium valuation in-line with other internally managed BDC peers

 

Portfolio Investments

 

The total value of our investments was $642.9 million at December 31, 2018. During the quarter ended December 31, 2018, the Company originated $39.1 million of investments and had $43.8 million of repayments, resulting in net repayments of $4.7 million. As of December 31, 2018, the Company had investments in securities of 62 portfolio companies with approximately 64.0% consisting of senior secured first lien investments, 5.7% consisting of senior secured second lien investments, 0.5% consisting of unsecured debt, 11.8% in MCC Senior Loan Strategy JV and 18.0% in equities / warrants. As of December 31, 2018, the weighted average yield based upon the cost basis of our income bearing portfolio investments, excluding cash and cash equivalents, was 9.6%.

 

Results of Operations

 

For the three months ended December 31, 2018, the Company reported net investment income per share and net loss per share of $0.03 and $(0.18), respectively, calculated based upon the weighted average shares outstanding. Adjusted net investment income was $0.05 per share, which excludes $0.9 million of expenses associated with the pending merger. As of December 31, 2018, the Company’s NAV was $5.61 per share.

 

Investment Income

 

For the three months ended December 31, 2018, total investment income was $14.2 million and consisted of $11.6 million of portfolio interest income, $2.1 million of dividend income, and $0.5 million of fee income.

 

Expenses

 

For the three months ended December 31, 2018, total expenses were $12.4 million and consisted of the following: base management fees of $3.2 million, interest and financing expenses of $6.0 million, professional fees of $1.2 million, administrator expenses of $1.0 million, directors’ fees of $0.3 million, and other general and administrative related expenses of $0.7 million.

 

3

 

 

Net Investment Income

 

For the three months ended December 31, 2018, the Company reported net investment income of $1.8 million, or $0.03, on a weighted average per share basis.

 

Net Realized and Unrealized Gains/Losses

 

For the three months ended December 31, 2018, the Company reported a net realized loss of $(56.7) million and net unrealized appreciation of $45.0 million.

 

For the three months ended December 31, 2018, the Company reported a loss on extinguishment of debt of $(0.1) million.

 

Liquidity and Capital Resources

 

During the period, the Company redeemed $12.0 million in aggregate principal amount of 6.125% unsecured notes due 2023 (the “2023 Notes”) and $1.1 million in aggregate principal amount of 5.55% unsecured notes due 2024 (the “2024 Notes”).

 

As of December 31, 2018, the Company had a cash balance of $62.7 million, of which, $32.3 million was held by Medley SBIC, LP.

 

As of December 31, 2018, the Company had $135.0 million outstanding in SBA-guaranteed Debentures, $74.0 million outstanding in aggregate principal amount of 6.5% unsecured notes due 2021, $77.8 million outstanding in aggregate principal amount of the 2023 Notes, and $120.2 million outstanding in aggregate principal amount of the 2024 Notes.

 

Dividend Declaration

 

On February 10, 2019, the Company’s board of directors declared a dividend of $0.05 per share, payable on March 12, 2019, to stockholders of record at the close of business on February 22, 2019. The Company has identified 70.7%, or $0.0354 per share, of this distribution as an interest-related dividend generally exempt from U.S. nonresident withholding tax. This information is subject to change and the specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year.

 

Webcast/Conference Call

 

The Company will host an earnings conference call and audio webcast at 10:00 a.m. (Eastern Time) on Tuesday, February 12, 2019. The Company plans to place additional materials related to the earnings announcement, including a slide presentation, on its website prior to the conference call.

 

All interested parties may participate in the conference call by dialing (888) 637-5728 approximately 5-10 minutes prior to the call, international callers should dial (484) 747-6636. Participants should reference Medley Capital Corporation and the Conference ID: 6887228. Following the call you may access a replay of the event via audio webcast. This conference call will be broadcast live over the Internet and can be accessed by all interested parties through the Company’s website, http://www.medleycapitalcorp.com. To listen to the live call, please go to the Company’s website at least 15 minutes prior to the start of the call to register and download any necessary audio software. For those who are not able to listen to the live broadcast, a replay will be available shortly after the call on the Company’s website.

 

4

 

 

Financial Statements

 

Medley Capital Corporation

Consolidated Statements of Assets and Liabilities

(in thousands, except share and per share data)

 

  

December 31,

2018

  

September 30,

2018

 
   (unaudited)     
ASSETS        
Investments at fair value        
Non-controlled/non-affiliated investments (amortized cost of $407,062 and $428,718, respectively)  $372,306   $393,149 
Affiliated investments (amortized cost of $115,054 and $102,547, respectively)   110,753    100,641 
Controlled investments (amortized cost of $185,010 and $233,422, respectively)   159,819    161,640 
Total investments at fair value   642,878    655,430 
Cash and cash equivalents   62,696    75,666 
Interest receivable   4,930    6,377 
Other assets   3,202    3,421 
Deferred offering costs   365    355 
Receivable for dispositions and investments sold   290    160 
Fees receivable   109    187 
Total assets  $714,470   $741,596 
           
LIABILITIES          
Notes payable (net of debt issuance costs of $7,431 and $8,238, respectively)  $264,597   $276,909 
SBA debentures payable (net of debt issuance costs of $1,987 and $2,095, respectively)   133,013    132,905 
Interest and fees payable   4,646    3,280 
Management and incentive fees payable   3,185    3,348 
Accounts payable and accrued expenses   2,117    2,936 
Administrator expenses payable   1,032    808 
Deferred revenue   151    192 
Due to affiliate   75    39 
Total liabilities  $408,816   $420,417 
           
NET ASSETS          
Common stock, par value $0.001 per share, 100,000,000 common shares authorized, 54,474,211 and 54,474,211 common shares issued and outstanding, respectively  $54   $54 
Capital in excess of par value   698,587    698,587 
Total distributable earnings/(loss)   (392,987)   (377,462)
Total net assets   305,654    321,179 
Total liabilities and net assets  $714,470   $741,596 
           
NET ASSET VALUE PER SHARE  $5.61   $5.90 

 

5

 

 

Medley Capital Corporation

Consolidated Statements of Operations

(in thousands, except share and per share data)

 

  

For the three months ended

December 31

 
   2018   2017 
   (unaudited)   (unaudited) 
INVESTMENT INCOME        
Interest from investments        
Non-controlled/non-affiliated investments:        
Cash  $8,078   $13,090 
Payment-in-kind   572    1,641 
Affiliated investments:          
Cash   752    577 
Payment-in-kind   972    850 
Controlled investments:          
Cash   78    430 
Payment-in-kind   1,028    719 
Total interest income   11,480    17,307 
Dividend income (net of provisional taxes of $0 and $0, respectively)   2,100    1,444 
Interest from cash and cash equivalents   161    31 
Fee income   461    1,849 
Total investment income   14,202    20,631 
           
EXPENSES          
Base management fees   3,185    4,068 
Incentive fees        
Interest and financing expenses   6,009    6,759 
Professional fees   1,201    586 
Administrator expenses   1,032    868 
General and administrative   604    757 
Directors fees   292    147 
Insurance   119    133 
Expenses before management and incentive fee waivers   12,442    13,318 
Management fee waiver        
Incentive fee waiver        
Total expenses net of management and incentive fee waivers   12,442    13,318 
Net investment income before excise taxes   1,760    7,313 
Excise tax expense       (134)
NET INVESTMENT INCOME   1,760    7,179 
           
REALIZED AND UNREALIZED GAIN/(LOSS) ON INVESTMENTS          
Net realized gain/(loss) from investments          
Non-controlled/non-affiliated investments   (5,184)   (21)
Affiliated investments        
Controlled investments   (51,538)    
Net realized gain/(loss) from investments   (56,722)   (21)
Net unrealized appreciation/(depreciation) on investments          
Non-controlled/non-affiliated investments   812    (34,470)
Affiliated investments   (2,395)   4,283 
Controlled investments   46,591    (9,005)
Net unrealized appreciation/(depreciation) on investments   45,008    (39,192)
Change in provision for deferred taxes on unrealized (appreciation)/depreciation on investments       90 
Net loss on extinguishment of debt   (123)    
Net realized and unrealized gain/(loss) on investments   (11,837)   (39,123)
NET INCREASE/(DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS  $(10,077)  $(31,944)
           
WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS PER COMMON SHARE  $(0.18)  $(0.59)
WEIGHTED AVERAGE - BASIC AND DILUTED NET INVESTMENT INCOME PER COMMON SHARE  $0.03   $0.13 
WEIGHTED AVERAGE COMMON STOCK OUTSTANDING - BASIC AND DILUTED   54,474,211    54,474,211 
DIVIDENDS DECLARED PER COMMON SHARE  $0.10   $0.16 

 

6

 

 

Non-GAAP Financial Measures

 

We make reference to certain non-GAAP financial measures in this press release. The following table presents a reconciliation of net investment income to adjusted net investment income:

 

  

For the three months

ended

December 31, 2018

 
   Total   Per Share 
         
Net investment income  $1,759,118   $0.03 
Add back Merger related expenses   888,384    0.02 
Adjusted net investment income  $2,647,502   $0.05 

 

Merger related expenses primarily consist of professional fees and proxy solicitation expenses.

Per share amounts are based on 54,474,211 weighted average shares outstanding for the period.

 

ABOUT MEDLEY CAPITAL CORPORATION

 

Medley Capital Corporation is a closed-end, externally managed business development company (“BDC”) that trades on the New York Stock Exchange (NYSE: MCC) and the Tel Aviv Stock Exchange (TASE: MCC). Medley Capital Corporation’s investment objective is to generate current income and capital appreciation by lending to privately-held middle market companies, primarily through directly originated transactions, to help these companies expand their businesses, refinance and make acquisitions. Our portfolio generally consists of senior secured first lien loans and senior secured second lien loans. Medley Capital Corporation is externally managed by MCC Advisors LLC, which is an investment adviser registered under the Investment Advisers Act of 1940, as amended. For additional information, please visit Medley Capital Corporation at www.medleycapitalcorp.com.

 

ABOUT MCC ADVISORS LLC

 

MCC Advisors LLC is a subsidiary of Medley Management Inc. (NYSE: MDLY, “Medley”). Medley is an alternative asset management firm offering yield solutions to retail and institutional investors. Medley’s national direct origination franchise is a premier provider of capital to the middle market in the U.S. Medley has $4.8 billion of assets under management in two business development companies, Medley Capital Corporation (NYSE: MCC) (TASE: MCC) and Sierra Income Corporation, a credit interval fund, Sierra Total Return Fund (NASDAQ:SRNTX) and several private investment vehicles. Over the past 15 years, we have provided capital to over 400 companies across 35 industries in North America.[4] For additional information, please visit Medley Management Inc. at www.mdly.com.

 

Medley LLC, the operating company of Medley Management Inc., has outstanding bonds which trade on the New York Stock Exchange under the symbols (NYSE:MDLX) and (NYSE:MDLQ). Medley Capital Corporation is dual-listed on the New York Stock Exchange (NYSE:MCC) and the Tel Aviv Stock Exchange (TASE: MCC) and has outstanding bonds which trade on both the New York Stock Exchange under the symbols (NYSE:MCV), (NYSE:MCX) and the Tel Aviv Stock Exchange under the symbol (TASE: MCC.B1).

 

No Offer or Solicitation

 

The information in this communication is for informational purposes only and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities or the solicitation of any vote or approval in any jurisdiction pursuant to or in connection with the proposed transactions or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

 

7

 

 

Important Information and Where to Find It

 

In connection with the proposed transactions, Sierra has filed with the Securities and Exchange Commission (the “SEC”) a Registration Statement on Form N-14 that includes a joint proxy statement of Sierra, the Company, and MDLY and, with respect to Sierra, constitutes a prospectus (collectively, the “Joint Proxy Statement/Prospectus”). The Joint Proxy Statement/Prospectus, as applicable, was first mailed or otherwise delivered to stockholders of Sierra, the Company, and MDLY on or about December 21, 2018. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT SIERRA, THE COMPANY, AND MDLY, THE PROPOSED TRANSACTIONS AND RELATED MATTERS. Investors and security holders can obtain the Joint Proxy Statement/Prospectus and other documents filed with the SEC by Sierra, the Company, and MDLY, free of charge, from the SEC’s web site at www.sec.gov and from Sierra’s website (www.sierraincomecorp.com), the Company’s website (www.medleycapitalcorp.com), or MDLY’s website (www.mdly.com). Investors and security holders may also obtain free copies of the Joint Proxy Statement/Prospectus and other documents filed with the SEC from Sierra, the Company, or MDLY by contacting Sam Anderson, Medley’s Investor Relations contact, at 212-759-0777.

 

Participants in the Solicitation

 

Sierra, the Company, and MDLY and their respective directors, executive officers, other members of their management, employees and other persons may be deemed to be participants in the solicitation of proxies in connection with the proposed transactions. Information regarding the persons who may, under the rules of the SEC, be considered participants in the solicitation of the Sierra, the Company, and MDLY stockholders in connection with the proposed transactions is set forth in the Joint Proxy Statement/Prospectus filed with the SEC. More detailed information regarding the identity of potential participants, and their direct or indirect interests, by security holdings or otherwise, is set forth in the Joint Proxy Statement/Prospectus and in other relevant materials that may be with the SEC. These documents may be obtained free of charge from the sources indicated above.

 

Cautionary Statement Regarding Forward-Looking Statements

 

This communication contains “forward-looking” statements, including statements regarding the proposed transactions. Such forward-looking statements reflect current views with respect to future events and financial performance, and each of Sierra, the Company and MDLY may make related oral forward-looking statements on or following the date hereof. Statements that include the words “should,” “would,” “expect,” “intend,” “plan,” “believe,” “project,” “anticipate,” “seek,” “will,” and similar statements of a future or forward-looking nature identify forward-looking statements in this material or similar oral statements for purposes of the U.S. federal securities laws or otherwise. Because forward-looking statements, such as the date that the parties expect the proposed transactions to be completed and the expectation that the proposed transactions will provide sustainable and increased profits, greater likelihood of dividend growth, lower cost of capital and improved liquidity for Sierra, the Company, and MDLY stockholders and will be accretive to net investment income for both Sierra and the Company, include risks and uncertainties, actual results may differ materially from those expressed or implied and include, but are not limited to, those discussed in each of Sierra’s, the Company’s and MDLY’s filings with the SEC, and (i) the satisfaction or waiver of closing conditions relating to the proposed transactions described herein, including, but not limited to, the requisite approvals of the stockholders of each of Sierra, the Company, and MDLY, Sierra successfully taking all actions reasonably required with respect to certain outstanding indebtedness of the Company and MDLY to prevent any material adverse effect relating thereto, certain required approvals of the SEC and the Small Business Administration, the necessary consents of certain third-party advisory clients of MDLY, and any applicable waiting period (and any extension thereof) applicable to the transactions under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, shall have expired or been terminated, (ii) the parties’ ability to successfully consummate the proposed transactions, and the timing thereof, and (iii) the possibility that competing offers or acquisition proposals related to the proposed transactions will be made and, if made, could be successful. Additional risks and uncertainties specific to Sierra, the Company and MDLY include, but are not limited to, (i) the costs and expenses that Sierra, the Company and MDLY have, and may incur, in connection with the proposed transactions (whether or not they are consummated), (ii) the impact that any litigation relating to the proposed transactions may have on any of Sierra, the Company and MDLY, (iii) that projections with respect to dividends may prove to be incorrect, (iv) Sierra’s ability to invest our portfolio of cash in a timely manner following the closing of the proposed transactions, (v) the market performance of the combined portfolio, (vi) the ability of portfolio companies to pay interest and principal in the future; (vii) the ability of MDLY to grow its fee earning assets under management; (viii) whether Sierra, as the surviving company, will trade with more volume and perform better than the Company and MDLY prior to the proposed transactions; and (ix) negative effects of entering into the proposed transactions on the trading volume and market price of the Company’s or MDLY’s common stock. There can be no assurance of the level of any dividends to be paid, if any, following consummation of the merger.

 

8

 

 

The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements included in each of Sierra’s, the Company’s and MDLY’s filings with the SEC, including the Joint Proxy Statement/Prospectus relating to the proposed transactions, and in the “Risk Factors” sections of each of Sierra’s, the Company’s and MDLY’s most recent Annual Report on Form 10-K and most recent Quarterly Report on Form 10-Q. The forward- looking statements in this communication represent Sierra’s, the Company’s and MDLY’s views as of the date of hereof. Sierra, the Company and MDLY anticipate that subsequent events and developments will cause their views to change. However, while they may elect to update these forward-looking statements at some point in the future, none of Sierra, the Company or MDLY have the current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing Sierra’s, the Company’s or MDLY’s views as of any date subsequent to the date of this material.

 

SOURCE: Medley Capital Corporation

 

Investor Relations Contact:
Sam Anderson

Head of Capital Markets & Risk Management
Medley Management Inc.
212-759-0777

 

Media Contact:
Jonathan Gasthalter/Nathaniel Garnick

Gasthalter & Co. LP

212-257-4170

 

 

 

 

 

 

 
1 As disclosed in the Company’s Proxy Statement, Sierra Income Corporation (“Sierra”) expects the Combined Company’s distribution for the first twelve months following the closing of the Mergers will be $0.055 per share per month, which will consist of a regular base distribution per share of $0.045 and a supplementary distribution per share of $0.010. However, the Combined Company’s board of directors, in its sole discretion, will determine the amount of cash to be distributed to the Combined Company’s stockholders based on various factors including, but not limited to, its results of operations, cash flow and capital requirements, economic conditions, tax considerations, borrowing capacity and other factors, including debt covenant restrictions that may impose limitations on cash payments, future acquisitions and divestitures and any stock repurchase program. Consequently, the Combined Company’s distribution levels may not be as disclosed and may fluctuate based on most recently available information contained in the proxy
2 Source: Joint Proxy Statement/Prospectus, Management. MCC, Sierra and MDLY estimates per Management. Net investment income per share accretion assumes projected MDLY earnings. Merger is expected to result in an estimated 18.5% accretion of net investment income per share for MCC shareholders assuming flat MDLY earnings.
3 The Combined Company refers to Sierra, as the surviving entity following the consummation of proposed merger of Sierra, the Company, and MDLY, pursuant to that certain Agreement and Plan of Merger, dated as of August 9, 2018, by and between the Company and that certain Agreement and Plan of Merger, dated as of August 9, 2018, by and among MDLY, Sierra, and Sierra Management, Inc.
4 Medley Management Inc. is the parent company of Medley LLC and several registered investment advisors (collectively, “Medley”). Assets under management refers to assets of our funds, which represents the sum of the net asset value of such funds, the drawn and undrawn debt (at the fund level, including amounts subject to restrictions) and uncalled committed capital (including commitments to funds that have yet to commence their investment periods). Assets under management are as of September 30, 2018.

 

9